相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Loss of Taste and Smell as Distinguishing Symptoms of Coronavirus Disease 2019
Patrick Dawson et al.
CLINICAL INFECTIOUS DISEASES (2021)
Three Emerging Coronaviruses in Two Decades The Story of SARS, MERS, and Now COVID-19
Jeannette Guarner
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Philippe Colson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Coronavirus infections and immune responses
Geng Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Jasper Fuk-Woo Chan et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses
Jieliang Chen
MICROBES AND INFECTION (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
Jinoos Yazdany et al.
ANNALS OF INTERNAL MEDICINE (2020)
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19 A Living Systematic Review
Adrian V. Hernandez et al.
ANNALS OF INTERNAL MEDICINE (2020)
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
J. -M. Michot et al.
ANNALS OF ONCOLOGY (2020)
Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection
Louise Cunningham et al.
AUTOIMMUNITY REVIEWS (2020)
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
Lihua Zhu et al.
CELL METABOLISM (2020)
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
Li-Li Ren et al.
CHINESE MEDICAL JOURNAL (2020)
Could Chloroquine/Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
Maurizio Guastalegname et al.
CLINICAL INFECTIOUS DISEASES (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Ning Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Wei-jie Guan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
Ming Zhao
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Xiaochen Li et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
COVID-19 and Cancer: a Comprehensive Review
Rohit Gosain et al.
CURRENT ONCOLOGY REPORTS (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A New Symptom of COVID-19: Loss of Taste and Smell
Jean-Francois Gautier et al.
OBESITY (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical Characteristics of Covid-19 in China
Alexandre P. Zavascki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR
Jaegyun Lim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
Ariane J. Brown et al.
ANTIVIRAL RESEARCH (2019)
Mitochondrial MiRNA in Cardiovascular Function and Disease
Rui Song et al.
CELLS (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update
Qinghua Cao et al.
FASEB BIOADVANCES (2019)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity
Anna C. C. Aguiar et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy
Yu Zhang et al.
ENDOCRINE REVIEWS (2017)
Role of microRNA in metabolic shift during heart failure
Mark V. Pinti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Immunotherapeutic implications of IL-6 blockade for cytokine storm
Toshio Tanaka et al.
IMMUNOTHERAPY (2016)
MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets
Mitsuo Kato et al.
YEAR IN DIABETES AND OBESITY (2015)
Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors
Encouse B. Golden et al.
NEUROSURGICAL FOCUS (2015)
Diabetic nephropathy-emerging epigenetic mechanisms
Mitsuo Kato et al.
NATURE REVIEWS NEPHROLOGY (2014)
Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure
Brent A. Dickinson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure
Rusty L. Montgomery et al.
CIRCULATION (2011)
Non-coding RNAs in human disease
Manel Esteller
NATURE REVIEWS GENETICS (2011)
CCR5: From Natural Resistance to a New Anti-HIV Strategy
Lucia Lopalco
VIRUSES-BASEL (2010)
KIR2DL5 alleles mark certain combination of activating KIR genes
Z. Du et al.
GENES AND IMMUNITY (2008)
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
Jean-Marc Rolain et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets
Ernesto Estefania et al.
JOURNAL OF IMMUNOLOGY (2007)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
